Your session is about to expire
← Back to Search
Cognitive Behavioral Therapy for Pediatric OCD
Study Summary
This trial tests if teens with OCD can discontinue meds after getting extra help via CBT, and still stay symptom-free over 6 months.
- Obsessive-Compulsive Disorder
- Cognitive Behavioral Therapy
Eligibility Criteria
Inclusion Criteria
You will be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Side effects data
From 2021 Phase 4 trial • 12 Patients • NCT04135937Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- The child is experiencing severe thoughts of hurting themselves or others and needs medical help to stay safe.The child is currently receiving therapy for obsessive-compulsive disorder (OCD) at the same time as the study.
- Group 1: Continued SRI
- Group 2: Discontinuation titration to placebo
- Group 3: Open label CBT
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Is this scientific investigation admitting elderly individuals?
"As indicated in the study's inclusion criteria, prospective patients should be between the ages of 7 to 17. There are 259 studies for participants aged below 18 and 668 for those above 65 years old."
How many individuals have enrolled in the clinical trial thus far?
"Affirmative. Clinicaltrials.gov contains information that this clinical trial is currently soliciting patients, the initiation date being November 1st 2022 and most recently edited on November 2nd 2022. 200 individuals are sought from a single medical site for participation in this experiment."
Who is eligible to participate in this clinical trial?
"This trial seeks out two-hundred children between the ages of 7 and 17 who are diagnosed with obsessive compulsive disorder (OCD). Essential criteria for enrolment include: a KSADS score indicating OCD diagnosis lasting more than 6 months, symptom severity indicated by CY-BOCS ≥20, stable and maximally tolerated Selective Serotonin Reuptake Inhibitor (SSRI) medication usage for at least 12 weeks, Wechsler Abbreviated Scale for Intelligence (WASI) IQ of 85 or higher , English fluency from both child and parent participants, Texas (OCD). Essential criteria for enrolment include: a KSADS score indicating OCD diagnosis lasting more than 6 months, symptom severity indicated by CY-BOCS ≥20, stable and maximally tolerated Selective Serotonin Reuptake Inhibitor (SSRI) medication usage for at least 12 weeks, Wechsler Abbreviated Scale for Intelligence (WASI) IQ of 85 or higher , English fluency from both child and parent participants, Texas residence from those same individuals, meeting all"
Is it feasible to enrol in this experiment at present?
"Data on clinicaltrials.gov affirms that this research is seeking participants, with the original post being uploaded on November 1st 2022 and the last update occurring a day later."
Share this study with friends
Copy Link
Messenger